BioSpace News Archive

Business

Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call Scheduled for Today, Tuesday, May 14, 2024 at 5:00 pm ET

Vivos Therapeutics, Inc. today announced it plans to release its first quarter 2024 financial results after market close today, Tuesday, May 14, 2024.

May 14, 2024
·
4 min read
Business

MiNK Reports First Quarter 2024 Results

MiNK Therapeutics, Inc. today announced results for the first quarter 2024. MiNK executives will host a conference call and webcast at 8:30 a.m. ET to discuss the results and provide a corporate update.

May 14, 2024
·
5 min read
FDA

Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan

Profound Medical Corp. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for the Company’s second TULSA-AI module, Contouring Assistant, for use in conjunction with its TULSA-PRO® system.

May 14, 2024
·
8 min read
Provectus Biopharmaceuticals Announces Eight Presentations of Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2024 Annual Meeting

Provectus Biopharmaceuticals, Inc. were presented at the annual meeting of the Association for Research in Vision and Ophthalmology (“ARVO”), held May 5-9, 2024 in Seattle, Washington.

May 14, 2024
·
6 min read
Business

Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business Update

Palisade Bio, Inc. today reported its financial results for the first quarter 2024 and provided a business update.

May 14, 2024
·
10 min read
Business

Ocugen Provides Business Update with First Quarter 2024 Financial ResultsConference Call and Webcast Today at 8:30 a.m. ET

Ocugen, Inc. today reported first quarter 2024 financial results along with a general business update.

May 14, 2024
·
10 min read
Drug Development

Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer’s Disease at Discovery Europe 2024

Halia Therapeutics today announced the unveiling of a new clinical program evaluating its candidate HT-4253 for the treatment of Alzheimer’s disease.

May 14, 2024
·
4 min read
BioCapital

Precision for Medicine Opens Expanded State-of-the-Art Biomarker Research and Companion Diagnostic Laboratory in Frederick, Maryland

Precision for Medicine, a global leader in biomarker-driven clinical research and development supporting life sciences companies, announced the completion of a major expansion to its laboratory campus in Frederick, Maryland.

May 14, 2024
·
3 min read
Biotech Bay

Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturing

Elegen, the leader in next-generation DNA synthesis and production, announced a Series B financing of $35 million led by Triatomic Capital.

May 14, 2024
·
4 min read
Genetown

Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting

Takeda (TSE: 4502/NYSE:TAK) today announced that it will present data from its oncology pipeline and product portfolio at the 60th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held May 31-June 4, 2024, in Chicago, Ill.

May 14, 2024
·
6 min read